Inflammation and Alzheimer disease

Molecular and Chemical Neuropathology

Volumn 28, Issue 1-3, 1996, Pages 83-88

  Aisen, Paul S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

acute phase response; Alzheimer disease; complement cascade; inflammation; microglia; therapeutics

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID; ANTIMALARIAL AGENT; CELL MARKER; CHYMOTRYPSIN A; COLCHICINE; GLUCOCORTICOID; HLA DR3 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 6; PREDNISONE;

ALZHEIMER DISEASE; ANTIMICROBIAL ACTIVITY; CONFERENCE PAPER; DISEASE COURSE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; INFLAMMATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENILE PLAQUE; TISSUE INJURY; TREATMENT PLANNING;

EID: 0029818458     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815208     Document Type: Conference Paper

References (5)

1. Abraham C. R., Selkpe D. J., and Potter H. (1988) Immtmohistochemical identification of the-serine protease inhibitor alpha-1 antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. 1-antichymotrypsin is associated solely with amyloid deposits containing the jS-protein and is localized in specific cells of both normal and diseased brain. Neurobiol. Aging 11, 123-129.
3. Aisen P. S., Marin D., Altstiel L., Goodwin C., Baruch B., Jacobson R., Ryan T., and Davis K. L. A pilot study of prednisone in Alzheimer's disease. Dementia, in press.
4. Aisen P. S. and Davis K. L. (1994) Inflammatory mechanisms in Alzheimer's disease: Implications for therapy. Am. J. Psychiatry 151, 1105-1113.
5. Altstiel L. and Sperber K. (1991) Cytokines in Alzheimer's disease, Prog. Neuro. Psychopharmacol. Biol. Psychiat. 15, 481-495.